Joe Biden is set to lift sanctions on a police unit that monitors Chinese Uighurs in exchange for a crackdown on fentanyl exporters, in a controversial deal to be agreed with Xi Jinping.
The US president and his Chinese counterpart will hold a bilateral meeting in the margins of the Asia-Pacific Economic Co-operation summit in San Francisco on Wednesday – their first face-to-face engagement in a year.
Washington has asked China to crack down on exporters who send fentanyl or its components to suppliers in Mexico, who then traffick the drug into the United States.
In return, Beijing has asked the US government to end its sanctions on China’s forensic police institute, which has been accused of running mass surveillance on the Muslim Uighur people in Xinjiang province.
Details of the agreement were reported by Bloomberg, and have not been officially confirmed by the White House in advance of the meeting.
Mr Biden has said that cracking down on fentanyl is one of his top priorities but the opioid crisis in the United States has only worsened during his term in office, as large quantities of the drug are imported via Mexico.
Rights Violations
Chinese companies continue to export the drug’s ingredients to Mexico, where they are mixed, despite recent action by Beijing to limit the export of the required chemicals.
The US had previously asked China to expand its restrictions to cover the ingredients but Beijing refused, blaming American sanctions on the Chinese public security ministry’s institute of forensic science.
The institute was sanctioned in May 2020 by the Donald Trump administration, which said it was “complicit in human rights violations and abuses committed in China’s campaign of repression, mass arbitrary detention, forced labour and high-technology surveillance” against Uighurs and other minorities in Xinjiang.
Lifting sanctions on a state agency accused of repressing Uighurs will prove controversial with human rights groups who argue that the US should not pander to China on humanitarian issues in exchange for concessions elsewhere.
Earlier this month, the US Treasury sanctioned 13 people and 12 businesses in China it said were involved in producing and exporting fentanyl ingredients.
Wally Adeyemo, the deputy secretary at the US treasury, said the government was taking action “to expose and disrupt a network responsible for manufacturing and distributing illicit drugs, including fentanyl and other substances that take thousands of American lives each year”.
The sanctions were directed at people in China who produce Xylazine, a powerful sedative that is cut with fentanyl by suppliers in Mexico before the drug is trafficked into the United States.